# Lifepharma FZE – FDA Inspection, Aug 4, 2017

Source: https://www.keypedia.com/records/fda_inspections/lifepharma-fze/5945620b-3129-4277-8660-956bfbe7171b
Source feed: FDA_Inspections

> FDA inspection 1020298 of Lifepharma FZE, August 04, 2017. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020298
- Company Name: Lifepharma FZE
- Inspection Date: 2017-08-04
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Generic Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 1

## Related Documents

- [FDA Inspection 1191272 - 2022-11-24](https://www.keypedia.com/records/fda_inspections/lifepharma-fze/cac56b13-f6d6-4e19-9d79-f77379322949)
- FDA Inspection 1070936 - 2018-09-27

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/lifepharma-fze/9c7d558f-745a-4268-9330-151bf40ee32c

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
